DEA Opens Federal Weed HMO, Declares Adult Use a Preexisting Condition

More than 900 medical dispensaries made the first federal provider directory. Now the government must verify their suppliers, buy the growers’ crops, sell those crops back and make sure nobody has also been selling weed to adults.

WASHINGTON — At the inaugural orientation for America’s new Federal Marijuana Provider Network, more than 900 dispensaries were handed credentials confirming that the United States government now recognizes their marijuana as medicine.

A federal benefits coordinator congratulated the room. After decades of raids, arrests, asset forfeiture, punitive taxation and televised warnings about irreversible brain damage, the businesses were finally entering the legitimate healthcare system.

Then a dispensary operator raised his hand and asked whether he could buy weed.

The coordinator stopped smiling.

Welcome to the Network

O

n October 30, the Department of Justice announced that DEA had issued federal registrations to more than 900 medical marijuana dispensaries across Alabama, Florida, Mississippi, South Dakota, Texas, Virginia and West Virginia. It was the first major round of approvals under the April federal order that moved qualifying state-licensed medical marijuana into Schedule III while leaving adult-use marijuana and other cannabis activity in Schedule I.

The plant did not change. Its cannabinoid profile did not change. Nobody discovered a new molecule hiding beneath the Metrc tag. Marijuana became federally recognized medicine because the right license was touching it for the right purpose.

The inaugural class came entirely from markets without operational adult-use retail. Virginia permits adult possession but still has no recreational sales system. DEA therefore began its historic reconciliation with cannabis in seven states where nobody would immediately ruin the ceremony by pointing toward another register and asking why the weed over there was still a narcotic.

Before the first registrations were issued, DEA’s published list contained 6,983 timely applications: 4,197 dispensaries, 2,076 manufacturers and 710 distributors. The federal government approved more than 900 dispensaries first while manufacturers and distributors remained under additional review for inspections, production controls and quota determinations.

The pharmacies were now in network. The companies supplying the medicine were still completing onboarding.

The operator lowered his hand and opened the federal provider directory.

Please Confirm That Your Weed Is In Network

Businesses that submitted complete applications between April 28 and June 26 became “Timely Applicants.” Those applicants may continue conducting qualifying medical marijuana activity under their state licenses while DEA considers their applications.

DEA’s October 30 guidance explained who they can conduct that activity with. Timely applicants and federally registered businesses may engage in Schedule III medical marijuana transactions with other timely applicants and registrants. Transactions with companies outside that system could become grounds for application denial or registration revocation.

The dispensary operator searched for his usual cultivator.

The cultivator held an active state license. Its facility had passed inspections. Its products had been tested, tagged, tracked and taxed. It had supplied the dispensary for years without losing a truck, poisoning a patient or accidentally mailing a pallet to Nebraska.

But none of those qualifications answered the new question: Had the cultivator filed a complete DEA application before June 26?

State legality had become the insurance card. Federal application status was the network.

Timely applicants were given until November 29 to verify their counterparties and align their medical supply chains. Timely dispensaries and distributors may continue selling inventory acquired before DEA issued the guidance, including products obtained from sources outside the new federal circle. This created a temporary class of grandfathered weed: marijuana allowed to remain in commerce because it entered the system before the government finished deciding who was authorized to have grown it.

After the transition, the same state-compliant supplier could become an out-of-network provider. Its flower would remain tested. Its facility would remain licensed. The marijuana would not become more dangerous at midnight on November 29. It would simply become the kind of medicine that could cost another business its federal coverage.

The operator eventually found his cultivator’s document control number.

The federal benefits coordinator nodded. The weed was in network.

Now DEA just needed to buy it.

DEA Must Purchase Your Weed Before You Can Have It Back

The United States remains bound by the Single Convention on Narcotic Drugs, which requires government control over cannabis production used for medical and scientific purposes. To satisfy those treaty obligations, the federal rule establishes a nominal-price purchase-and-resale mechanism for registered marijuana manufacturers.

The manufacturer establishes a nominal price for its crop. DEA purchases the crop at that price. DEA then sells the crop back to the manufacturer, a related company or a subsidiary for the same price plus an administrative fee.

That is not an exaggeration added by Boof du Jour. It is the actual fucking rule.

A grower must cultivate the marijuana, harvest it, store it inside a facility accessible to DEA, establish a nominal sales price and temporarily sell the crop to the agency that spent decades confiscating marijuana from people. DEA then returns the crop to the business that grew it and charges an administrative fee for completing the circle.

The federal government has finally entered the cannabis industry, and its first innovation is making growers pay a convenience fee to regain custody of their own weed.

At the orientation, the cultivator rolled a cart of harvested cannabis across a strip of blue tape. A DEA employee pulled it onto the federal side, stamped a form and pushed it back. Another employee presented the administrative charge.

The crop had traveled four feet, changed ownership twice and satisfied an international treaty.

Everyone applauded because the alternative was doing it again.

Adult Use Arrives Without an Appointment

A second operator entered the orientation holding both a medical cannabis license and authorization to serve adult-use customers. Several states have spent years combining their marijuana programs through shared facilities, dual-purpose licenses, endorsements and integrated supply chains. Illinois officially permits medical and adult-use customers to be served at the same location. Other states allow the same licensee or corporate operation to participate in both markets.

The operator believed this made him experienced.

DEA viewed it as a preexisting condition.

In an October 27 order to show cause, the agency proposed denying the federal application of Minneapolis dispensary In-Dispensary LLC. One of DEA’s three stated grounds was Minnesota’s dual-purpose licensing structure, which permits a single licensee to dispense marijuana for medical and non-medical use.

DEA argued that such a license falls outside the federal definition of a state medical marijuana license.

Because adult-use activity remains federally prohibited, the agency also characterized non-medical dispensing as diversion and questioned whether Minnesota’s system provides sufficiently robust protection against it.

The order cited two additional Minnesota-specific concerns: veterans may qualify through identification and self-attestation rather than a practitioner’s written certification, and the state permits certain artificially derived cannabinoid products that remain federally problematic. The proposed denial is not final. The applicant may contest it or submit corrective action.

But the message delivered to every mixed-market operator was difficult to miss. The first federal approvals all went to medical-only retail markets. When a dual-purpose license reached DEA, the agency treated legal adult-use activity as evidence that the applicant might be doing too much marijuana to participate in the federal marijuana program.

The operator explained that medical and recreational inventory were tracked separately.

The coordinator asked whether the same employees handled both.

The operator said yes.

The coordinator asked whether the same security cameras watched both.

Yes.

The same vault?

Sometimes.

The same electricity?

Unfortunately.

A federal eligibility specialist circled “cannabis exposure” on the application and recommended that the operator avoid adult-use marijuana, cannabis businesses and establishments where cannabis might be present.

The operator asked where he was supposed to work.

The federal government handed him a brochure about personal responsibility.

The Molecule Receives Its Diagnosis

The federal distinction does not require one physical jar to jump between medical and recreational registers. Medical and adult-use inventory generally carries separate tracking identities, tax treatment and regulatory designations.

It does, however, allow separately tracked packages containing the same cultivar, grown by the same company under the same state testing standards, to occupy completely different federal realities.

The medical package may qualify as Schedule III. The adult-use package remains Schedule I, the same federal category as heroin.

One may be recognized as medicine because a qualifying patient obtained it through a protected medical channel. The other becomes contraband because a legal adult purchased it without turning the transaction into a healthcare appointment.

The cannabis itself does not know which one it is. The terpenes have not reviewed the patient certification. THC cannot distinguish pain management from a Saturday afternoon. Federal scheduling attaches to the licensed activity surrounding the product, not some newly discovered pharmacological difference between medical Blue Dream and the other fucking Blue Dream.

Nothing in the order broadly legalizes marijuana. It does not authorize recreational activity, automatically open interstate commerce or override state restrictions on importing and exporting cannabis. A federal registration cannot exceed the scope of the underlying state medical license and automatically suspends if that state license is suspended, revoked or expires.

The government did not reschedule marijuana as a plant.

It rescheduled a chain of custody.

Treasury Needs to Know Which Lightbulb Was Medical

The most valuable benefit in the new federal plan may be relief from Section 280E, the tax provision that prevents businesses trafficking in Schedule I or Schedule II substances from deducting ordinary expenses.

Qualifying medical marijuana activity has moved to Schedule III. Treasury and the IRS have said that the change is generally expected to remove 280E as a barrier for activities that no longer involve Schedule I or Schedule II substances.

Adult-use marijuana remains Schedule I. Adult-use activity therefore remains subject to 280E, leaving mixed operators with the small accounting challenge of dividing one business into federally deductible medicine and federally nondeductible drug trafficking.

Treasury has promised guidance addressing how businesses with multiple activities should apportion expenses. That guidance had not been issued when DEA announced the first registrations, so nobody currently has an official formula for dividing shared rent, payroll, utilities, security or administrative costs.

At orientation, an accountant began examining the dispensary floor plan.

The medical and adult-use operations shared an HVAC system. The accountant needed to determine which percentage of the air conditioning preserved medicine and which percentage provided climate control for narcotics. The security guard protected both inventories, but perhaps his left eye could be assigned to Schedule III while the right remained trapped under 280E. The bathroom was used by every employee, creating what Treasury will eventually classify as a mixed-purpose toilet.

The accountant asked whether the break-room microwave became deductible when a medical budtender reheated fish in it.

The IRS representative promised forthcoming guidance and left the building.

Historical Participation Is Not Covered

The federal network rewards a specific kind of compliance. A business needs a qualifying state medical license, the correct federal registration or timely-applicant status, acceptable patient-access rules and a supply chain populated by other applicants or registrants.

Helping build the legal industry earns no special federal status. Neither does surviving raids, banking closures, municipal bans, residency requirements, licensing lotteries, years of 280E taxation or the period when states deposited cannabis revenue while the federal government continued calling the businesses drug traffickers.

Adult-use operators cannot enter merely because their businesses are licensed, inspected, tested and tolerated by their states. Medical businesses that missed the original application window may still apply, but they do not receive the same pending-application protection as timely applicants. Dual-use businesses remain trapped inside an unresolved question about whether medical marijuana can retain its federal purity while sharing a corporate bloodstream with legal adult-use sales.

Federal recognition arrived as a new credential, not an apology.

The industry did not move into Schedule III together. The government carved a narrow medical network out of the state markets that already existed, then began checking whether the businesses inside had been associating with the wrong kind of legal weed.

Coverage Begins

By the end of orientation, the dispensary operator had a federal registration, a list of acceptable counterparties and instructions to keep every medical transaction inside the approved network. His cultivator had permission to continue operating while DEA considered its application, provided it completed the ceremonial sale and repurchase of its own crop. The accountant had an empty folder labeled “Forthcoming Guidance.” The dual-use operator had thirty days to explain why selling state-legal marijuana to adults should not disqualify him from selling state-legal marijuana to patients.

The federal government had accomplished something historic. More than 900 medical dispensaries were now registered inside a system that did not exist six months earlier. Qualifying businesses could receive enormous tax relief. Research opportunities could expand. State medical marijuana activity had achieved a level of federal recognition that generations of patients and advocates were told would never come.

But the contradiction at the center of American cannabis had not been resolved. It had been reorganized into a benefits package.

DEA approved the cleanest medical-only dispensaries first, left much of their upstream supply chain under review, created a closed network of acceptable counterparties, devised a process for buying marijuana from growers and selling it straight back, and signaled that businesses serving both patients and adults may be too involved with cannabis to qualify.

The War on Drugs did not end. It got a goddamn provider directory.